🔎 Trials Near Me

Home › Uterine Cancer › New York › New York City

Uterine Cancer clinical trials in New York City, NY

6 studies for Uterine Cancer are looking for participants at sites in and around New York City (within about 30 miles). Open a study to see who can join and how to contact the study team.

Recruiting for a study here? Feature it at the top of this page — $99 for 30 days →

Ocular Assessments in Patients Treated With Tivdak® in Recurrent or Metastatic Cervical Cancer

RecruitingPhase 4
  • Columbia University Medical Center - Herbert Irving Pavilion, New York
  • IP Address: Columbia University Medical Center/New York Presbyterian Hospital Research Pharmacy, New York
Ages 18 and older · Women · Updated Sep 25, 2026 · NCT06952660

Investigations of Reproductive Cancers in Women

RecruitingObservational study
  • Columbia University, New York
Ages 45 to 100 · Women · Updated Aug 17, 2026 · NCT06527157

Sacituzumab Govitecan in Combination With Cisplatin in Platinum Sensitive Recurrent Ovarian and Endometrial Cancer

RecruitingPhase 1/2
  • Icahn School of Medicine at Mount Sinai Division of Hematology and Medical Oncology, New York
Ages 18 and older · Women · Updated Aug 13, 2026 · NCT06040970

A Study to Assess the Efficacy and Safety of FORE8394 in Participants With Cancer Harboring BRAF Alterations

RecruitingPhase 2
  • Columbia University Irving Medical Center, New York
  • Memorial Sloan Kettering Cancer Center, New York
Ages 8 and older · All sexes · Updated Jul 27, 2026 · NCT05503797

NYSCF Scientific Discovery Biobank

RecruitingObservational study
  • New York Stem Cell Foundation Research Institute, New York
30 Days · All sexes · Updated Mar 3, 2025 · NCT06203106

About Uterine Cancer

Uterine cancer is a cancer that forms in tissues of the uterus. It is more likely to happen after menopause. There are things you can do that may help lower your risk.

More about Uterine Cancer on MedlinePlus

Uterine Cancer trials in other cities

Other studies in New York City

From ClinicalTrials.gov, data retrieved Oct 6, 2026. Each study sets its own eligibility; the study team decides who can join.